Subodh Verma




Please note: Dr. Verma will not take students in summer.

Dr. Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the University of Toronto. He is the current Canada Research Chair in Cardiovascular Surgery, having previously served as the Canada Research Chair in Atherosclerosis (2007-2017). Dr. Verma was recently awarded the 2021 Lister Prize in Surgery from the University of Toronto in recognition of his outstanding and continuing productivity of international stature. He is a past recipient of the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is an appointee of the American Association of Thoracic Surgeons (AATS) and a member of the College of New Scholars, Artists and Scientists, Royal Society of Canada. According to Google Scholar in April 2021, Dr. Verma has an h-index of 100 and his work has been cited over 50,000 times.

Dr. Verma has published extensively in highly impactful journals like the NEJM, Lancet, Circulation, JACC, Nature, and JCI. He is an Associate Editor of the European Heart Journal. Dr. Verma is an active contributor to Canadian clinical practice guidelines and co-authored the recently updated recommendations for atrial fibrillation, antiplatelet therapy, diabetes, and heart failure; he was a member of the 2018 AATS consensus guidelines committee on bicuspid aortic valve-related aortopathy. Dr. Verma has served in various capacities on the American Heart Association Council on Cardiovascular Surgery and Anesthesia since 2008.

Dr. Verma had/has leadership roles on 10 contemporary global heart failure trials – several of which have let to paradigm changes in how individuals all around the world who live with diabetes and heart failure are now managed. He founded and oversees the CardioLink platform at St Michael’s Hospital that is conducting cardiometabolic and surgically oriented RCTs and translational studies.

Dr. Verma leads a dynamic pre-clinical and translational research team that leverages pre-clinical disease models and clinical trial-derived data to identify novel mediators of cardiovascular and cardiometabolic disease as well as answer timely and relevant healthcare questions. His research has yielded 2 United States patents and is supported by several national peer-reviewed grants.


Recent Publications

  1. Hosseini, F, Malhi, N, Sellers, SL, Khan, N, Li, CK, Taylor, CM et al.. The Morphology of Coronary Artery Disease in South Asians versus White Caucasians and its Implications. Can J Cardiol. 2022; :. doi: 10.1016/j.cjca.2022.05.005. PubMed PMID:35568268 .
  2. Primary Panel:, Abramson, BL, Al-Omran, M, Anand, SS, Albalawi, Z, Coutinho, T et al.. Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. Can J Cardiol. 2022;38 (5):560-587. doi: 10.1016/j.cjca.2022.02.029. PubMed PMID:35537813 .
  3. Dhingra, NK, Verma, S, Yanagawa, B, Hibino, M. Aortic valve neocuspidization and its technical nuance. J Card Surg. 2022; :. doi: 10.1111/jocs.16604. PubMed PMID:35535024 .
  4. Evans, M, Chandramouli, AS, Faurby, M, Matthiessen, KS, Mogensen, PB, Verma, S et al.. Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET). Diabetes Obes Metab. 2022; :. doi: 10.1111/dom.14703. PubMed PMID:35504854 .
  5. Hibino, M, Dhingra, NK, Verma, R, Yanagawa, B, Bisleri, G, Verma, S et al.. An Arrow Through the Heart. J Invasive Cardiol. 2022;34 (5):E414-E415. . PubMed PMID:35501114 .
  6. Heerspink, HJL, Furtado, RHM, Berwanger, O, Koch, GG, Martinez, F, Mukhtar, O et al.. Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial. Clin J Am Soc Nephrol. 2022; :. doi: 10.2215/CJN.14231021. PubMed PMID:35483733 .
  7. Adamson, C, Docherty, KF, Heerspink, HJL, de Boer, RA, Damman, K, Inzucchi, SE et al.. Initial Decline ("dip") in Estimated Glomerular Filtration Rate Following Initiation of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF. Circulation. 2022; :. doi: 10.1161/CIRCULATIONAHA.121.058910. PubMed PMID:35442064 .
  8. Dhingra, NK, Verma, S, Yanagawa, B, Hibino, M. Complete transcatheter versus complete surgical management for combined aortic stenosis and coronary artery disease: A false dichotomy?. J Card Surg. 2022; :. doi: 10.1111/jocs.16531. PubMed PMID:35434807 .
  9. Lopaschuk, GD, Hess, DA, Verma, S. Ketones regulate endothelial homeostasis. Cell Metab. 2022;34 (4):513-515. doi: 10.1016/j.cmet.2022.03.008. PubMed PMID:35385704 .
  10. Bergmark, BA, Marston, NA, Bramson, CR, Curto, M, Ramos, V, Jevne, A et al.. Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70. Circulation. 2022;145 (18):1377-1386. doi: 10.1161/CIRCULATIONAHA.122.059266. PubMed PMID:35369705 PubMed Central PMC9047643.
Search PubMed

Affiliations & Other Activities

  • Cardiac Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor of Surgery and Pharmacology & Toxicology, University of Toronto
  • Canada Research Chair in Cardiovascular Surgery